Physical characterization and optimisation of dissolution parameters of prochlorperazine maleate coevaporates

No abstract is available for this paper.

• Publication year

  1998

• Venue

  International Journal of Pharmaceutics

• Publication date

  1998-01-26

• Fields of study

  Materials Science, Chemistry

• Identifiers
  DOI 10.1016/S0378-5173(97)00318-9
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• A new type of a pH-independent controlled release tablet

  1991cited by this paper
• Pharmaceutical Dissolution Testing

  1991cited by this paper
• Retardation of weakly basic drugs with diffusion tablets

  1990cited by this paper
• Pharmaceutical applications of solid dispersion systems.

  1971cited by this paper

• Formulation, in vitro evaluation and characterization of atorvastatin solid dispersion

  2020cites this paper
• Formulation and evaluation of liquisolid compacts of itraconazole to enhance its oral bioavailability.

  2020cites this paper
• REVIEW ON: CONVENTIONAL AND NOVEL TECHNIQUES FOR SOLUBILITY ENHANCEMENT

  2019cites this paper
• The dissolution enhancement of piroxicam in its physical mixtures and solid dispersion formulations using gluconolactone and glucosamine hydrochloride as potential carriers

  2015cites this paper
• DIFFERENT APPROACHES TOWARDS THE SOLUBILITY ENHANCEMENT OF DRUG:A REVIEW

  2014cites this paper
• Dissolution enhancement of drugs. part i: technologies and effect of carriers

  2010cites this paper
• Preparation and Characterization of Solid Dispersions of Piroxicam with Hydrophilic Carriers

  2007cites this paper
• Optimizing drug delivery systems using systematic "design of experiments." Part II: retrospect and prospects.

  2005cites this paper
• Basic Drug—Enterosoluble Polymer Coevaporates: Development of Oral Controlled Release Systems

  2004cites this paper
• Solubility enhancers for oral drug delivery

  2004cites this paper
• Utilization of DSC for Pharmaceutical crystal form quantitation

  2004cites this paper
• Factors affecting incorporation of drug into solid solution with HPMCP during solvent change co-precipitation.

  2002cites this paper
• Design, optimization and evaluation of domperidone coevaporates.

  2000cites this paper
• Enhanced dissolution of furosemide by coprecipitating or cogrinding with crospovidone

  1998cites this paper